Skip to content

Talphera, Inc. TLPH Net interest and investment income (loss)

Net interest and investment income (loss) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s net interest and investment income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s net interest and investment income (loss)?
Talphera, Inc. (TLPH) reported net interest and investment income (loss) of $169K in Q1 2026.
How has Talphera, Inc.'s net interest and investment income (loss) changed year-over-year?
Talphera, Inc.'s net interest and investment income (loss) increased by 144.9% year-over-year, from $69K to $169K.
What is the long-term trend for Talphera, Inc.'s net interest and investment income (loss)?
Over 4 years (2021 to 2025), Talphera, Inc.'s net interest and investment income (loss) has grown at a 36.9% compound annual growth rate (CAGR), from $124K to $436K.